Abstract:Induced pluripotent stem cells (iPSCs) have tremendous potential as a tool for disease modeling, drug testing, and other applications. Since the generation of iPSCs "captures" the genetic history of the individual cell that was reprogrammed, iPSC clones (even those derived from the same individual) would be expected to demonstrate genetic heterogeneity. To assess the degree of genetic heterogeneity, and to determine whether some cells are more genetically "fit" for reprogramming, we performed exome sequencing on 24 mouse iPSC clones derived from skin fibroblasts obtained from two different sites of the same 8-week-old C57BL/6J male mouse. While no differences in the coding regions were detected in the two parental fibroblast pools, each clone had a unique genetic signature with a wide range of heterogeneity observed among the individual clones: a total of 383 iPSC variants were validated for the 24 clones (mean 16.0/clone, range 0-45). Since these variants were all present in the vast majority of the cells in each clone (variant allele frequencies of 40-60% for heterozygous variants), they most likely preexisted in the individual cells that were reprogrammed, rather than being acquired during reprogramming or cell passaging. We then tested whether this genetic heterogeneity had functional consequences for hematopoietic development by generating hematopoietic progenitors in vitro and enumerating colony forming units (CFUs). While there was a range of hematopoietic potentials among the 24 clones, only one clone failed to differentiate into hematopoietic cells; however, it was able to form a teratoma, proving its pluripotent nature. Further, no specific association was found between the mutational spectrum and the hematopoietic potential of each iPSC clone. These data clearly highlight the genetic heterogeneity present within individual fibroblasts that is captured by iPSC generation, and suggest that most of the changes are random, and functionally benign.

Naive Pluripotent Stem Cells Exhibit Phenotypic Variability that Is Driven by Genetic Variation

Deconstructing Transcriptional Heterogeneity in Pluripotent Stem Cells

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures

Unique Features of Mutations Revealed by Sequentially Reprogrammed Induced Pluripotent Stem Cells

Individual variation in the emergence of anterior-to-posterior neural fates from human pluripotent stem cells

Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines

Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility

Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential

A pluripotent stem cell platform for in vitro systems genetics studies of mouse development

Neural Differentiation of Human Induced Pluripotent Stem Cells Follows Developmental Principles but with Variable Potency

Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine

Complex regulatory networks influence pluripotent cell state transitions in human iPSCs

Network plasticity of pluripotency transcription factors in embryonic stem cells

Adipogenic Placenta-Derived Mesenchymal Stem Cells Are Not Lineage Restricted by Withdrawing Extrinsic Factors: Developing a Novel Visual Angle in Stem Cell Biology

Abnormalities in Human Pluripotent Cells Due to Reprogramming Mechanisms

Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells

Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies

Somatic mutations alter the differentiation outcomes of iPSC-derived neurons

Propagating pluripotency – The conundrum of self‐renewal

Culture‐acquired genetic variation in human pluripotent stem cells: Twenty years on